Literature DB >> 24596721

Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India.

Manisha Sharma1, Rahul Mannan1, Mohit Madhukar2, Sanjay Navani3, Mridu Manjari4, Tejinder Singh Bhasin4, Karamjit Singh Gill4.   

Abstract

INTRODUCTION: The distribution of the major subtypes of non-Hodgkin's lymphoma (NHL) differs across geographic regions. This study, from the north Indian state of Punjab, has incorporated immunophenotypic findings while investigating the distribution of NHL subtypes based on World Health Organization (WHO)/ Revised European-American Classification of Lymphoid Neoplasms (REAL) system of classification. PATIENTS AND METHODS: Over all seventy seven cases of lymphoma over a period of one year (between April 2012 and April 2013) were diagnosed in the Department of Pathology, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar (Punjab). Of these 30 cases (39%) were of Hodgkin's Lymphoma (HL) and 47 cases (61%) were of Non Hodgkins lymphoma NHL. Of the total of cases of lympho-proliferative disorders, the diagnosis of NHL was done by light microscopy alone. All the cases diagnosed provisionally as NHL were taken up for immunophenotyping with Immunohistochemical (IHC) studies. There was 100 % concordance between the light microscopy and IHC studies. The individual NHL cases were classified according to the WHO/REAL classification according to the positive or relevant negative immonophenotypic expression and tabulated to ascertain the morphological spectrum of NHL in this part of the country.
RESULTS: B-cell lymphomas formed 89.3%, whereas T-cell lymphomas formed 10.7% of the NHLs. Diffuse Large B-Cell Lymphoma (DLBCL) was the most common subtype (46.8% of all NHLs). B-cell small lymphocytic lymphoma, Mantle-Cell Lymphoma (MCL), marginal zone B-cell lymphomas (including MALT lymphomas), Diffuse, mixed small cleaved cell and large-cell type and Follicular centre-cell lymphomas amounted to 17%, 12.8%, 2.1%, 2.1% and 4.3%, respectively. Among the T-cell lymphomas, T-cell lymphoblastic lymphoma, anaplastic large-cell lymphomas of T/null-cell type, and Angioimmunoblastic T-cell lymphoma (AITL) accounted for 6.4%, 2.1%, and 2.1% of all NHL cases, respectively.
CONCLUSIONS: The distribution of NHL subtypes in India shows disparity with those from the rest of the world. Follicular Lymphoma (FL) and MCL are less common in India compared to Europe and the USA. Peripheral T-cell lymphomas and T/NK-cell lymphomas of nasal and nasal types, which are common in many other Asian countries, are also less prevalent. T-cell lymphoblastic lymphoma and anaplastic large T/null cell lymphoma are more prevalent in India.

Entities:  

Keywords:  B-cell lymphomas; Immunophenotyping; Non Hodgkins lymphoma; T-cell lymphomas; WHO/REAL classification

Year:  2013        PMID: 24596721      PMCID: PMC3939585          DOI: 10.7860/JCDR/2014/8173.3988

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases.

Authors:  Deepti Aggarwal; Ruchika Gupta; Sompal Singh; Madhur Kudesia
Journal:  Hematology       Date:  2011-07       Impact factor: 2.269

3.  Non-Hodgkin's lymphoma: is India ready to incorporate recent advances in day to day practice?

Authors:  Saraschandra Vallabhajosyula; Gunjan Baijal; B M Vadhiraja; Donald J Fernandes; M S Vidyasagar
Journal:  J Cancer Res Ther       Date:  2010 Jan-Mar       Impact factor: 1.805

4.  Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.

Authors:  Andrea Altieri; Justo Lorenzo Bermejo; Kari Hemminki
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

Review 5.  The new World Health Organization classification of lymphomas: the past, the present and the future.

Authors:  J K Chan
Journal:  Hematol Oncol       Date:  2001-12       Impact factor: 5.271

6.  Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population.

Authors:  Jenika M Howell; Iwona Auer-Grzesiak; Jianguo Zhang; Christopher N Andrews; Douglas Stewart; Stefan J Urbanski
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

7.  Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis.

Authors:  Somanath Padhi; Tara Roshni Paul; Sundaram Challa; Aruna K Prayaga; Senthil Rajappa; D Raghunadharao; Rajlaxmi Sarangi
Journal:  Asian Pac J Cancer Prev       Date:  2012

8.  An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA.

Authors:  Briseis Aschebrook-Kilfoy; Donne Bennett D Caces; Nicholas J Ollberding; Sonali M Smith; Brian C-H Chiu
Journal:  Leuk Lymphoma       Date:  2013-02-07

Review 9.  Adult lymphoblastic lymphoma.

Authors:  Craig A Portell; John W Sweetenham
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

10.  Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms.

Authors:  Sajid Mushtaq; Nooren Akhtar; Shahid Jamal; Nadira Mamoon; Tahir Khadim; Tariq Sarfaraz; Amin Waqar
Journal:  Asian Pac J Cancer Prev       Date:  2008 Apr-Jun
View more
  6 in total

1.  Primary non-hodgkin lymphoma of lateral skull base mimicking a trigeminal schwannoma: case report.

Authors:  Liu Yang; Wen Li; Min Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.

Authors:  Wardah Aslam; Maryam Habib; Saeeda Aziz
Journal:  Cureus       Date:  2022-06-03

3.  Diagnostic Utility of PAX5 in Hodgkin and Non-Hodgkin Lymphoma: A Study from Northern India.

Authors:  Nidhi Johri; Shashikant C U Patne; Mallika Tewari; Mohan Kumar
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 4.  Epstein-Barr Virus: Diseases Linked to Infection and Transformation.

Authors:  Hem C Jha; Yonggang Pei; Erle S Robertson
Journal:  Front Microbiol       Date:  2016-10-25       Impact factor: 5.640

5.  Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary Care Institute in Southern India.

Authors:  Mary Theresa Sylvia; Biswajit Dey; Debdatta Basu; Sajini Elizabeth Jacob; Rakhee Kar; Biswajit Dubashi
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-11-01       Impact factor: 2.576

6.  Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.

Authors:  Doris Kafita; Trevor Kaile; Evans Malyangu; Rabecca Tembo; Ephraim Zulu; Chrispin Chisanga; Annie Kalonda; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2018-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.